focus -WSS

focus

author：comprehensive 2025-08-25 07:28:56 - browse：67

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： A clever new way to fix Medicaid and graduate medical education

knowledge

WSS

Meta looks to target Twitter with a rival app called Threads

HPV cancer vaccine study demonstrates efficacy

Option Care buys Amedisys in $3.6 billion home care deal

Meta looks to target Twitter with a rival app called Threads

STAT Executive Editor Rick Berke on STAT's 8th birthday

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Executive Editor Rick Berke on STAT's 8th birthday

Medicare proposal to cover medical devices draws a mixed reaction

Can food be medicine? And other questions about a new push

Psychedelics group wrestles with new pharma identity

Brain 'hot spot' may explain why African Americans feel greater pain

Continuity nursing helped my family in our darkest PICU moments

White House calls on federal agencies to crack down on AI abuses

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Bacterial infection may be ‘key event’ in endometriosis, study says

leisure time

Abortion clinic in Cancun will cater to Americans

Free speech concerns arise in wake of journal editor Eisen's firing

A new study asks: Are we harming blood donors by taking blood?

Senate panel clears PBM, hopsital reforms

Senate panel clears PBM, hopsital reforms

New case study details death in closely watched Alzhiemer's trial

leisure time

explore

knowledge

focus